Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1990
Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL)T H Snider, M G Wientjes, R L Joiner, et al.Cancer Research|August 1, 1991
Pharmacodynamics of mitomycin C in cultured human bladder tumorsT D Schmittgen, M G Wientjes, R A Badalament, et al.Cancer Research|November 15, 1995
Design and analysis of in vitro antitumor pharmacodynamic studiesJ E Kalns, N J Millenbaugh, M G Wientjes, et al.The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumorsY Zhang, S Song, F Yang, et al.AAPS Pharmsci|December 14, 2001
Time- and concentration-dependent penetration of doxorubicin in prostate tumorsJ H Zheng, C T Chen, J L Au, et al.Pharmaceutical Research|April 1, 1996
Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in ratsT K Yeh, H J Kang, M G Wientjes, et al.Journal of Chromatography|March 12, 1982
Reversed-phase ion-pair high-performance liquid chromatographic assay of 5-fluorouracil, 5'-deoxy-5-fluorouridine, their nucleosides, mono-, di-, and triphosphate nucleotides with a mixture of quaternary ammonium ionsJ L Au, M G Wientjes, C M Luccioni, et al.The Journal of Urology|November 7, 2001
Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumorsD Li, Y Gan, M G Wientjes, et al.Cancer Research|July 15, 1993
Penetration of mitomycin C in human bladderM G Wientjes, R A Badalament, R C Wang, et al.The Journal of Urology|August 1, 1994
Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patientsM Chai, M G Wientjes, R A Badalament, et al.Pageof 7